Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFMW) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Sunshine Biopharma (SBFMW) over the last 13 years, with Q3 2025 value amounting to -$36168.0.

  • Sunshine Biopharma's Other Working Capital Changes rose 5680.66% to -$36168.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $166842.0, marking a year-over-year increase of 84106.83%. This contributed to the annual value of $207167.0 for FY2024, which is 87983.73% up from last year.
  • As of Q3 2025, Sunshine Biopharma's Other Working Capital Changes stood at -$36168.0, which was up 5680.66% from -$115617.0 recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Other Working Capital Changes ranged from a high of $568981.0 in Q1 2024 and a low of -$736637.0 during Q2 2024
  • For the 5-year period, Sunshine Biopharma's Other Working Capital Changes averaged around -$6284.5, with its median value being -$21172.0 (2022).
  • In the last 5 years, Sunshine Biopharma's Other Working Capital Changes skyrocketed by 114848.02% in 2021 and then tumbled by 186044.99% in 2022.
  • Over the past 5 years, Sunshine Biopharma's Other Working Capital Changes (Quarter) stood at $4579.0 in 2021, then tumbled by 1860.45% to -$80611.0 in 2022, then skyrocketed by 433.85% to $269120.0 in 2023, then soared by 70.39% to $458558.0 in 2024, then tumbled by 107.89% to -$36168.0 in 2025.
  • Its last three reported values are -$36168.0 in Q3 2025, -$115617.0 for Q2 2025, and -$139931.0 during Q1 2025.